<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for IMMU</title>
    <link />
    <description>Headlines for Immunomedics, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Commit To Purchase Immunomedics At $2, Earn 22.8% Annualized</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11932702/1/commit-to-purchase-immunomedics-at-2-earn-228-annualized.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 23 May 2013 14:17:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Health Care Stocks Under $10 to Watch</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/3-health-care-stocks-under-10-watch.html-0.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 09 May 2013 21:40:00 GMT</pubDate>
    </item>
    <item>
      <title>Immunomedics' CEO Discusses F3Q13 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1421451-immunomedics-ceo-discusses-f3q13-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 17:43:06 GMT</pubDate>
    </item>
    <item>
      <title>In Danish Laboratories, Hope Looms Large for a Permanent HIV Cure</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/sectors/biotech-pharma/articles/hiv-update-hiv-cure-biotech-news/5/8/2013/id/49661.aspx</link>
      <author>Minyanville</author>
      <pubDate>Wed, 08 May 2013 13:42:00 GMT</pubDate>
    </item>
    <item>
      <title>In Danish Laboratories, Hope Looms Large for a Permanent HIV Cure</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/in-danish-laboratories-hope-looms-large-for-a-permanent-hiv-cure-cm244657.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Wed, 08 May 2013 13:42:00 GMT</pubDate>
    </item>
    <item>
      <title>Immunomedics Reports Three New Patent Wins</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3565352/immunomedics-reports-three-new-patent-wins.aspx</link>
      <author>Benzinga</author>
      <pubDate>Tue, 07 May 2013 08:34:10 GMT</pubDate>
    </item>
    <item>
      <title>Tackling Cancer: Non-Hodgkin Lymphoma's Biggest Current &amp; Upcoming Players</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/17/tackling-cancer-non-hodgkin-lymphomas-biggest-curr/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 17 Apr 2013 14:20:00 GMT</pubDate>
    </item>
    <item>
      <title>Three Biotech Stocks With Low Price But Great Potential</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1343641-three-biotech-stocks-with-low-price-but-great-potential.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 16 Apr 2013 06:17:19 GMT</pubDate>
    </item>
    <item>
      <title>Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential Therapeutics for Solid a</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3485681/immunomedics-develops-t-cell-redirecting-bispecific-antibodies-as-potential-thera.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 10 Apr 2013 08:32:12 GMT</pubDate>
    </item>
    <item>
      <title>Immunomedics Announces First Results of Labetuzumab-SN-38 in Colorectal Cancer Study</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3481760/immunomedics-announces-first-results-of-labetuzumab-sn-38-in-colorectal-cancer-st.aspx</link>
      <author>Benzinga</author>
      <pubDate>Tue, 09 Apr 2013 08:34:16 GMT</pubDate>
    </item>
    <item>
      <title>3 Radiotherapy Companies That Could Make Big Gains In 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1326931-3-radiotherapy-companies-that-could-make-big-gains-in-2013.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 08 Apr 2013 10:14:25 GMT</pubDate>
    </item>
    <item>
      <title>Immunomedics' Strengthened Balance Sheet Supports A Compelling Trade Ahead Of Presentations</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1314981-immunomedics-strengthened-balance-sheet-supports-a-compelling-trade-ahead-of-presentations.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 02 Apr 2013 13:12:45 GMT</pubDate>
    </item>
    <item>
      <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130402-000215&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Tue, 02 Apr 2013 09:02:59 GMT</pubDate>
    </item>
    <item>
      <title>Immunomedics To Receive $16.7 Million Payment to Resolve Finra Proceedings</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130401-000292&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Mon, 01 Apr 2013 18:11:00 GMT</pubDate>
    </item>
    <item>
      <title>Immunomedics Settles FINRA Arbitration Proceedings, to Receive Gross Settlement of $18M</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3461792/immunomedics-settles-finra-arbitration-proceedings-to-receive-gross-settlement-of.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 01 Apr 2013 17:04:04 GMT</pubDate>
    </item>
    <item>
      <title>Why Merrimack Is Poised to Outperform</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/20/why-merrimack-is-poised-to-outperform/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 20 Mar 2013 15:02:00 GMT</pubDate>
    </item>
    <item>
      <title>A Quick Look At 8 Biotechs Ready To Gain Momentum</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1263951-a-quick-look-at-8-biotechs-ready-to-gain-momentum.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 11 Mar 2013 15:44:16 GMT</pubDate>
    </item>
    <item>
      <title>Immunomedics Has A Cheap, Deep And Recently Capitalized Pipeline</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1239921-immunomedics-has-a-cheap-deep-and-recently-capitalized-pipeline.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 01 Mar 2013 12:45:16 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Lows</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3357952/stocks-hitting-52-week-lows.aspx</link>
      <author>Benzinga</author>
      <pubDate>Fri, 22 Feb 2013 10:18:26 GMT</pubDate>
    </item>
    <item>
      <title>Biotech and BioHeath Stocks Raising Capital, Secondary Offerings</title>
      <link>http://www.fool.com/news/xt/247wallst/247wallst.com/2013/02/22/biotech-and-bioheath-stocks-raising-capital-secondary-offerings/.aspx</link>
      <author>247wallst</author>
      <pubDate>Fri, 22 Feb 2013 09:15:15 GMT</pubDate>
    </item>
  </channel>
</rss>
